
Intellia Therapeutics
A leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$1.2b
Authorizing premium user...